Novo's Ozempic, Wegovy picked for US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.
President-elect Donald Trump says he “most likely” will give TikTok 90 more days to work out a deal that would allow the ...
Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...
Sanders: I welcome the Biden administration’s announcement that Medicare will finally begin to negotiate the price of Ozempic and Wegovy.
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
Medicare Part D plans can only cover obesity ... Lilly and its main rival in the obesity-drug race, Denmark's Novo Nordisk (NVO) (DK:NOVO.B), are conducting trials to evaluate GLP-1 drugs as ...
If you were enrolled in Medicare Part B before 2025, your premium may increase. For new enrollees in 2025, the standard monthly premium is set at $185. However, individuals earning more than $ ...
Trump said he got Mexico to agree to stop migration through Mexico. Trump claims his influence caused the Israel-Hezbollah truce, that he got Canada to stop the U.S. opioid crisis and that he caused ...
The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback